empty

Cancer

14 results found for: Cancer

Public would talk to community pharmacist before GP about cancer

Many people would talk to a community pharmacist more often than a GP about the early warning signs of cancer.

Boys to be offered HPV vaccine for first time

Boys aged 12 and 13 will be offered the free HPV vaccine from September for the first time.

Obesity trumps smoking as cause of some cancers

Obesity has trumped cancer as the leading cause of four cancers.

Clinical briefing: How far have we come on cancer survival?

Crucial advances have been made but there are still barriers to improving survival rates

Occupational sun exposure linked to cancers

Occupational sun exposure causes about one in 50 cutaneous malignant melanomas, equivalent to approximately one death from, and five new cases of, the cancer each week in Britain, new figures suggest

Scenario: Chemotherapy & hair loss

Sarah Forster has been diagnosed with breast cancer and is due to have chemotherapy. She asks to talk to Parveen

HealthWatch: Cancer kills more than heart disease

Deaths from cancer in Britain now outnumber those from heart disease for both men and women

Warning as skin cancer rates double in twenty years

Melanoma UK issues warning after new data reveals melanoma rates have more than doubled since 1995

BOPA symposium: community pharmacists welcome

This year's BOPA symposium includes for the first time a dedicated workstream for community pharmacists

Aspirin could cut GI cancer risk

Using aspirin long-term could reduce the risk of gastrointestinal tract malignancies

Cancer death rate falls

Cancer death rates in the UK have fallen by almost 10 per cent over 10 years, according to Cancer Research UK

Public still underestimates obesity-cancer link

Forty-one per cent of adults in Britain don’t know that being overweight increases cancer risk

Cancer screening works

Screening is more likely to pick up early cancers than GP referral or emergency presentation, new research finds

Cyramza’s new cancer indications

The European Commission recently approved two new indications for ramucirumab (Cyramza)



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.